CSI Market
Sign In | Register

Biomarin Pharmaceutical Inc (BMRN) Annual Balance Sheets

Annual · GAAP · USD millions
Access BMRN quarterly Balance Sheets →
Looking at balance sheet data from Biomarin Pharmaceutical Inc through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1,311.68
Available-for-sale Securities, Debt Securities, Current MA248.93
Cash & Short-term Investments1,559.00
Accounts receivable908.21
Inventories1,298.88
Other Current Assets185.78
Total Current Assets3,953.49
Equipment/Property/Plant Net952.51
Goodwill net196.20
Intangible Assets213.84
Long-term investments492.24
Other Assets, Noncurrent2,277.99
Total Assets7,594.02
Liabilities
Accounts Payable and Accrued Liabilities, Current LI759.03
Convertible Debt, Current LO0.00
Other Liabilities, Current0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities759.03
Convertible Debt, Noncurrent LO597.18
Total Long-term Debt597.18
Other liabilities, Noncurrent150.82
Total Liabilities1,507.02
Stockholders' Equity
Common Stock Value0.19
Additional Paid In Capital Common Stock5,956.58
Retained Earnings / Accumulated Deficit154.21
Defined Benefit Plan and Other-10.51
Other Equity-13.47
Common Stockholder's Equity6,087.00
Total Stockholder's Equity6,087.00
Liabilities & Stockholder's Equity7,594.02
4 historic quarters locked

Sign in to unlock the full Biomarin Pharmaceutical Inc balance sheet history.

Sign In Create Free Account

About Biomarin Pharmaceutical Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: bmrn-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001048477-26-000004

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License